PTX3 and renal cell carcinoma: It can be hypothesized that AREG released by RCC cells stimulates PTX3 expression in MSCs, that in turn acts in an autocrine manner (to enhance the expression of CD44 by MSCs) and in a paracrine way (to enhance HA production by RCC cells) (Fig. 4).